| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1499184A2 Methods and compositions for treating ectoparasite infestation |
| 01/26/2005 | EP1499175A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP1406871A4 Process for the production of n- 3-(3-cyanopyrazolo 1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) |
| 01/26/2005 | EP1406610B1 Use of substituted gamma-lactone compounds as medicaments |
| 01/26/2005 | EP1399164B1 Metal salts as antimycotic agents |
| 01/26/2005 | EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/26/2005 | EP1373255B1 Process for the preparation of imidazole compounds |
| 01/26/2005 | EP1320359B1 Thermogelling biodegradable aqueous polymer solution |
| 01/26/2005 | EP1318800B1 1-amino-alkylcyclohexanes as trypanocidal agents |
| 01/26/2005 | EP1307463B1 Pyrrolo 2,1-b]-[1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1282417B1 Creatinine biosensor |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1276504B1 Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent |
| 01/26/2005 | EP1265942B1 Use of poly(diallylamine) polymers |
| 01/26/2005 | EP1248629B1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 01/26/2005 | EP1233748B1 Retinaldehyde combination with antifungal activity |
| 01/26/2005 | EP1231926B1 Biomolecular complex formed between hyaluronic acid and a biomolecule, its method of manufacture and medical uses thereof |
| 01/26/2005 | EP1189874B1 Excitatory amino acid receptor modulators |
| 01/26/2005 | EP1187612B1 Use of riluzole for the treatment of multiple sclerosis |
| 01/26/2005 | EP1185524B1 3-heteroarylalkyl substituted gaba analogs |
| 01/26/2005 | EP1165091B1 Pharmaceutical emulsions for retroviral protease inhibitors |
| 01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
| 01/26/2005 | EP1131062B1 Injectable propofol formulations |
| 01/26/2005 | EP1127133B1 Polypeptide mediating cell permeability |
| 01/26/2005 | EP1120409B1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 01/26/2005 | EP1117409B1 Benzenesulfonyl(thio)ureas in combination with beta-blockers for the treatment of dysfunctions of the autonomous nervous system |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP1037604B1 Pharmaceutical aerosol compositions |
| 01/26/2005 | EP1017835A4 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy |
| 01/26/2005 | EP1007001B1 Nimesulide topical formulations in the form of liquid crystals |
| 01/26/2005 | EP1001961B1 Substituted tetrahydropyrane derivatives and method for producing same |
| 01/26/2005 | EP0994655B1 Satiety product |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0975637B1 Amidino-camptothecin derivatives |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0942736B1 Use of an estrogen for the prevention and treatment of ischemic damage |
| 01/26/2005 | EP0934412B1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
| 01/26/2005 | EP0914110B1 Method of modulating microcirculation |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | EP0854702B1 Antimicrobial compositions containing a c 3-c 6 alcohol |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | EP0769968B1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 01/26/2005 | EP0725826B1 Improvements relating to cancer therapy |
| 01/26/2005 | EP0706370B2 Use of non-ionic surfactants in stable topical retinoid compositions |
| 01/26/2005 | CN1571793A Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1571787A Quinuclidine derivatives processes for preparing them and their uses as M2 and/or M3 muscarinic receptor inhibitors |
| 01/26/2005 | CN1571784A Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 01/26/2005 | CN1571783A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/26/2005 | CN1571782A Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571780A Synthetic method of 2-(2-nitroethylenyl)-furan and its purpose as anti-coccidium agent |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571766A Novel compounds, their preparation and use |
| 01/26/2005 | CN1571678A Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 01/26/2005 | CN1571675A Treatment and diagnosis of insulin-resistant states |
| 01/26/2005 | CN1571674A Use of histamine to treat liver disease |
| 01/26/2005 | CN1571673A Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 01/26/2005 | CN1571672A Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 01/26/2005 | CN1571671A Drugs comprising combination of triazaspiro [5.5] undecane derivative with cytochrome p450 isozyme 3A4 inhibitor and/or P-glycoprotein inhibitor |
| 01/26/2005 | CN1571670A Treating sexual desire disorders with flibanserin |
| 01/26/2005 | CN1571669A Novel combination |
| 01/26/2005 | CN1571668A Salts formed of an AT1-receptor antagonist and a cardiovascular agent |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571666A Freeze-dried pharmaceutical preparation |
| 01/26/2005 | CN1571665A Substituted N-phenyl 2-hydroxy-2-methyl-3, 3, 3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 01/26/2005 | CN1571664A Percutaneous absorption preparations |
| 01/26/2005 | CN1571663A Dosage forms, devices and methods of treatment |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571661A Taste masking spill-resistant formulation |
| 01/26/2005 | CN1571660A Solid pharmaceutical agent formulation for a piperazine urea derivative |
| 01/26/2005 | CN1571659A Granules containing acid-unstable chemical in large amount |
| 01/26/2005 | CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide |
| 01/26/2005 | CN1571656A Method for treating non-neuropathic pain |
| 01/26/2005 | CN1571637A Use of cystathionine |
| 01/26/2005 | CN1569905A Malonic selenium bridged bicyclodextrin platinum complex, its preparation method and uses |
| 01/26/2005 | CN1569904A Anti AIDS activity compound and its preparation method |
| 01/26/2005 | CN1569902A Active oligose derivative and its preparation method |
| 01/26/2005 | CN1569886A Radix asparagi steroid saponin extract and its preparing process and application |
| 01/26/2005 | CN1569884A Method for preparing astragaloside and its use in preparation of drug for preventing and treating diabetic nephropathy |
| 01/26/2005 | CN1569883A Pineapple anhydride compound and its use |
| 01/26/2005 | CN1569881A CpG-containing single chain deoxy-oligonucleotide having anti-influenza virus |
| 01/26/2005 | CN1569878A siRNA nucleic acid sequence for SARS coronavirus causing gene and its pharmaceutical use |
| 01/26/2005 | CN1569873A Antisense nucleic acid sequence for SARS coronavirus gene and its pharmaceutical use |
| 01/26/2005 | CN1569872A Antisense nucleic acid for inhibiting SARS virus gene expression and its use |
| 01/26/2005 | CN1569870A Nucleotide analogs with six-membered rings |
| 01/26/2005 | CN1569869A Chinese chestnut flower flavone compounds |
| 01/26/2005 | CN1569868A Pineapple flavonoid glycoside compound and its use |
| 01/26/2005 | CN1569867A Preparation method and use of skunk bush extract morroniside |
| 01/26/2005 | CN1569862A Anti-tumor platinum (II) complex |
| 01/26/2005 | CN1569861A Pharmaceutical acid addition salt of adefovir dipivoxil and its pharmaceutical use |
| 01/26/2005 | CN1569849A Rosa banksiae general lactone extract and its preparing process and application |
| 01/26/2005 | CN1569848A Ligustilide for treating ischemic heart disease and its preparing method |